Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2024-01-25

FDA Approved: ACETAZOLAMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for acetazolamide by Hikma Pharmaceuticals USA Inc., resulting in labeling and/or manufacturing changes reflected by the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACETAZOLAMIDE (acetazolamide)

Snippet

SUPPL AP for ACETAZOLAMIDE (ACETAZOLAMIDE)